References
EMD Serono. Ontario Reimburses CIS Indication for REBIF(Rm), a First-Line Treatment for Multiple Sclerosis. Media Release : 25 May 2015. Available from: URL: http://www.emdserono.ca
Sanofi. Prince Edward Island funds treatment with AUBAGIO(Tm) for Relapsing Remitting Multiple Sclerosis. Media Release : 25 May 2015. Available from: URL: http://www.sanofi.com
Rights and permissions
About this article
Cite this article
Canadian MS patients gain access to interferon-β-1a and teriflunomide. PharmacoEcon Outcomes News 729, 33 (2015). https://doi.org/10.1007/s40274-015-2190-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-015-2190-y